Masimo Co. (NASDAQ:MASI) Receives Consensus Rating of "Moderate Buy" from Analysts

Masimo Co. (NASDAQ:MASI - Get Free Report) has received a consensus rating of "Moderate Buy" from the six ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $191.60.

MASI has been the subject of several recent research reports. Piper Sandler restated an "overweight" rating and issued a $200.00 price objective (down from $215.00) on shares of Masimo in a report on Wednesday. Raymond James cut their price objective on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research report on Thursday, April 10th. Wells Fargo & Company lowered their price target on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, BTIG Research set a $193.00 target price on shares of Masimo and gave the company a "buy" rating in a research report on Wednesday.

Insiders Place Their Bets

In other news, COO Bilal Muhsin sold 30,000 shares of Masimo stock in a transaction on Monday, March 10th. The stock was sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the sale, the chief operating officer now directly owns 24,172 shares of the company's stock, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Craig B. Reynolds sold 2,053 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $166.13, for a total value of $341,064.89. Following the transaction, the director now owns 16,581 shares of the company's stock, valued at $2,754,601.53. This trade represents a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MASI. Deutsche Bank AG increased its position in shares of Masimo by 1.5% during the first quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider's stock worth $1,051,000 after acquiring an additional 92 shares during the period. Bank of Nova Scotia acquired a new stake in Masimo in the 1st quarter valued at about $15,528,000. PNC Financial Services Group Inc. raised its position in Masimo by 21.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 5,684 shares of the medical equipment provider's stock valued at $947,000 after purchasing an additional 999 shares in the last quarter. Commerce Bank grew its position in shares of Masimo by 2.5% during the first quarter. Commerce Bank now owns 5,024 shares of the medical equipment provider's stock worth $837,000 after buying an additional 124 shares in the last quarter. Finally, Wealthquest Corp acquired a new position in shares of Masimo during the first quarter worth about $352,000. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Trading Up 2.3 %

Shares of NASDAQ:MASI traded up $3.60 during trading hours on Tuesday, hitting $157.18. 1,594,616 shares of the company's stock traded hands, compared to its average volume of 660,400. Masimo has a 1 year low of $101.61 and a 1 year high of $194.88. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The firm has a market capitalization of $8.52 billion, a P/E ratio of 108.40 and a beta of 1.23. The business has a fifty day moving average price of $161.66 and a 200-day moving average price of $166.75.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.12. The firm had revenue of $372.00 million for the quarter, compared to analysts' expectations of $367.79 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business's revenue for the quarter was down 24.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. Equities analysts expect that Masimo will post 4.1 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.